Jupiter Asset Management LTD Protagonist Therapeutics, Inc Transaction History
Jupiter Asset Management LTD
- $9.74 Billion
- Q1 2025
A detailed history of Jupiter Asset Management LTD transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Jupiter Asset Management LTD holds 168,063 shares of PTGX stock, worth $9.27 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
168,063Holding current value
$9.27 Million% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding PTGX
# of Institutions
304Shares Held
61.3MCall Options Held
1.01MPut Options Held
555K-
Farallon Capital Management LLC San Francisco, CA6.11MShares$337 Million1.7% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$318 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.72MShares$315 Million4.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.28MShares$236 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3MShares$165 Million5.07% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $2.71B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...